3.4 Immunization Services & Documentation
Key Takeaways
- Immunization services and documentation is a named Medication Use Process competency, spanning indications, contraindications, storage and handling, administration technique, and adverse-reaction management.
- Live attenuated vaccines (MMR, varicella, intranasal influenza, oral typhoid) are generally contraindicated in pregnancy and significant immunosuppression; two live vaccines not given the same day are separated by about 4 weeks.
- When both pneumococcal conjugate (PCV) and polysaccharide (PPSV23) products are indicated in series, the conjugate is given first, then the polysaccharide after the recommended interval.
- Cold-chain integrity is essential: most inactivated vaccines are refrigerated at 2-8 C, several live vaccines are frozen, and temperature excursions must be assessed before use.
- Pharmacists must recognize true contraindications (e.g., severe allergic reaction to a prior dose or component) versus precautions and manage anaphylaxis with intramuscular epinephrine.
Why Immunization Is Now Explicitly Tested
The current NABP content outline names immunization services and documentation as a Medication Use Process competency, reflecting the pharmacist's expanded role as an immunizer. The exam expects you to judge whether a vaccine is indicated, recognize a true contraindication, apply spacing and sequencing rules, store and handle product correctly, administer by the right route and site, document properly, and manage adverse reactions.
Vaccine Types: Live vs Inactivated
The single most important classification is whether a vaccine is live attenuated or inactivated/subunit, because it drives contraindications and spacing.
| Type | Examples | Key implication |
|---|---|---|
| Live attenuated | MMR, varicella, zoster (live form), intranasal influenza, oral typhoid, yellow fever, rotavirus | Generally avoided in pregnancy and significant immunosuppression; separate two live injectable vaccines by ~4 weeks if not same-day |
| Inactivated / subunit / toxoid / mRNA / recombinant | Most influenza, Tdap, hepatitis A/B, HPV, pneumococcal, recombinant zoster, COVID-19 | No live-organism risk; can generally be co-administered with other vaccines without required spacing |
Inactivated vaccines have no required spacing relative to live vaccines and can usually be given on the same day as any other vaccine.
Key Indications and Contraindications by Vaccine
The exam expects you to know who is indicated and who has a true contraindication (versus a precaution that may allow vaccination with caution).
| Vaccine | High-yield indication / note | Key contraindication or caution |
|---|---|---|
| Influenza (inactivated) | All persons aged 6 months and older, annually | Severe allergy to a prior dose/component; egg allergy is no longer a barrier with standard precautions |
| Tdap / Td | Tdap once for adults, then Td/Tdap booster; Tdap each pregnancy (27-36 weeks) | Encephalopathy after a prior dose (for pertussis component) |
| Pneumococcal (PCV, PPSV23) | Older adults and at-risk adults/children per current schedule | Severe allergy to a component or prior dose |
| Recombinant zoster (RZV) | Adults 50+ (and immunocompromised 19+); 2 doses; not live | Severe allergy to a component |
| Hepatitis B | Universal; adults through 59, and 60+ with risk | Severe allergy (e.g., to yeast) |
| HPV | Routine adolescents; catch-up per schedule | Severe allergy; defer in pregnancy |
| MMR / varicella (live) | Non-immune persons | Pregnancy; significant immunosuppression |
Exam distinction: A contraindication (severe allergic reaction to a prior dose/component; live vaccine in pregnancy or significant immunosuppression) means do not give. A precaution (e.g., moderate-to-severe acute illness) usually means defer until resolved, not permanent avoidance.
Spacing, Sequencing, and Special Rules
Reason from principles rather than memorizing a calendar:
- Two live injectable vaccines not given on the same day should be separated by at least 4 weeks; if given less than 4 weeks apart (but not same day), the second is generally repeated.
- Pneumococcal sequencing: when both a conjugate (PCV) and polysaccharide (PPSV23) are indicated, give the conjugate first, then the polysaccharide after the recommended interval.
- Minimum intervals apply to multi-dose series (hepatitis B, recombinant zoster, HPV); a dose given too early does not count and must be repeated.
- Antibody-containing products (immune globulin, blood) can blunt the response to certain live vaccines (MMR, varicella), requiring a delay.
- Tetanus wound management depends on wound type and the number/timing of prior tetanus doses, and may add tetanus immune globulin for high-risk wounds in undervaccinated patients.
Exam cue: A vignette giving two live vaccines on different days less than 4 weeks apart is testing the 4-week live-live rule; the second dose generally must be repeated.
Cold Chain, Storage, and Handling
Vaccine potency depends on an unbroken cold chain.
| Storage condition | Typical products |
|---|---|
| Refrigerated, 2-8 C (36-46 F) | Most inactivated vaccines (influenza, Tdap, hepatitis, pneumococcal, recombinant zoster) |
| Frozen | Several live vaccines (e.g., varicella-containing); follow product labeling |
| Ultra-cold / product-specific | Certain mRNA products per current labeling |
Principles tested on the exam:
- Use a calibrated digital data logger and document temperatures; do not store vaccines in the refrigerator door or near vents.
- A temperature excursion requires quarantining affected product and contacting the manufacturer or health department before use — do not assume it is still usable.
- Reconstituted vaccines and opened multidose vials have limited beyond-use times; protect light-sensitive products and rotate stock by expiration.
Administration, Documentation, and Adverse Reactions
Route and Site
Most adult vaccines are given intramuscularly (IM) in the deltoid with an appropriately sized needle; some (MMR, varicella, recombinant zoster uses IM) are subcutaneous. Correct technique avoids injury and ensures immunogenicity.
Documentation
Federal law (the National Childhood Vaccine Injury Act) requires recording the vaccine name and manufacturer, lot number and expiration, date and site/route of administration, the administering person, and provision of the Vaccine Information Statement (VIS) with its edition date. Many jurisdictions require reporting to an immunization registry (IIS).
Managing Adverse Reactions
- Anaphylaxis (rare) is treated with prompt intramuscular epinephrine (adult 0.3-0.5 mg of 1 mg/mL), airway support, and activation of emergency services; every immunizing site must stock epinephrine.
- Syncope is common shortly after vaccination, especially in adolescents; observe seated for about 15 minutes and prevent fall injury.
- Serious adverse events following vaccination are reported to the Vaccine Adverse Event Reporting System (VAERS), the dedicated pathway (distinct from MedWatch for drugs).
A 30-year-old pregnant patient asks about catching up on vaccines. Which vaccine is generally CONTRAINDICATED during pregnancy?
A patient received a live varicella vaccine 10 days ago and now needs the live MMR vaccine, which was not given the same day. What is the correct action?
A vaccine refrigerator shows that the temperature dropped outside the 2-8 C range overnight. What is the most appropriate immediate action?
Both a pneumococcal conjugate (PCV) and the polysaccharide (PPSV23) vaccine are indicated for an adult in a series. What is the correct sequencing principle?
A patient develops anaphylaxis minutes after an intramuscular vaccine in the pharmacy. What is the first-line pharmacologic treatment?